SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an immuno-oncology company focused on bispecific antibody development, today announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets. “With […]
FGIS’s aflatoxin testing program to renew usage of Charm’s Water Extraction Technology, as well as award contract for five years. LAWRENCE, Mass.— Charm Sciences, Inc. announces that the United States Department of Agriculture’s Federal Grain Inspection Service (USDA-FGIS) has renewed the usage of the ROSA® WET®-S5 Aflatoxin Quantitative Test. This lateral flow test was first approved in […]
— Panel 1 Targets SARS-CoV-2 Spike Protein; Panel 2 Targets Human ACE2 — SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of two new SARS-CoV-2 antibody panels designed for research use only. The […]
Cambridge, UK: Fluidic Analytics, a five-year old company based in Cambridge, UK, has announced the global launch of the Fluidity One‑W Serum. The new instrument provides quantitative insights into the antibody response to COVID‑19 that cannot easily be obtained with traditional antibody tests. The Fluidity One‑W Serum has been developed to allow researchers to characterize […]
SAN DIEGO — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the emergence of the COVID-19 outbreak, Exonbio has developed a comprehensive portfolio of SARS-CoV-2 recombinant rabbit antibodies using its proprietary Single Plasma cell INterrogation (SPIN®) platform. […]
Features water-based testing strips and handheld reader delivering convenience and accuracy WALTHAM, Mass — PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its AuroFlow® AQ Mycotoxin Platform. This new solution includes strip test versions for Total Aflatoxin, Deoxynivalenol (DON), Fumonisin, Ochratoxin A, Zearalenone and T-2/HT-2. Lab professionals, technicians and farmers can utilize […]
Findings from newly published research demonstrate promise of ultra-sensitive biomarker technology to identify and define high-risk populations through quantification of interferon (IFN) type I BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that researchers across the globe are deploying its Simoa® technology to profile innate […]
Perten Glutomatic® 2000 System delivers touchscreen UI, automation and LIMS-connectivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the Perten Glutomatic® 2000 System for gluten quantity and quality testing of wheat, durum, semolina and flour. The solution features the new Perten Glutomatic 2000 instrument with a modern user interface and simplified […]
SOUTH SAN FRANCISCO, Calif. & BOSTON, Mass.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced a partnership for the engineering and optimization of novel antibodies for the treatment of […]
Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors Cambridge and Wetherby, UK: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Integumen plc (AIM: SKIN) (“Integumen”) to evaluate recently generated Affimer reagents that bind […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
